Evaluation of perfluorooctanoate for potential genotoxicity
John L Butenhoff1, Gerald L Kennedy2, Reinhard Jung3
1Medical Department, 3M Company, St. Paul, MN 55144, USA.
Toxicology Reports
|October 1, 2017
Summary
Perfluorooctanoate (PFOA) was evaluated in fifteen genotoxicity assays, including mutation and chromosomal damage studies. The results demonstrate no direct mutagenic or genotoxic risk associated with PFOA exposure.
Area of Science:
- Toxicology
- Environmental Health
- Genotoxicity Testing
Background:
- Perfluorooctanoate (PFOA) is a stable industrial surfactant detected in environmental and biological samples.
- Concerns regarding PFOA's potential human health hazards necessitate comprehensive genotoxicity assessments.
Purpose of the Study:
- To report the results of fifteen unpublished genotoxicity assays for PFOA.
- To evaluate the mutagenic and genotoxic potential of PFOA across various test systems.
Main Methods:
- Conducted seven mutation assays (bacterial reverse mutation, yeast gene conversion, mammalian cell forward mutation).
- Performed seven chromosomal damage assays (mammalian cell aberration, in vivo micronucleus).
- Included an in vitro cell transformation assay and utilized a mammalian hepatic microsomal activation system.
Main Results:
- The majority of assays showed no evidence of mutagenicity or genotoxicity.
- Limited positive findings at high, cytotoxic concentrations were attributed to cellular disruption, not specific genotoxic effects.
- Results are consistent with PFOA's physicochemical properties and other published genotoxicity studies.
Conclusions:
- The comprehensive genotoxicity data indicate an absence of direct mutagenic or genotoxic risk from PFOA.
- Findings support the safety profile of PFOA concerning genetic damage.
Related Concept Videos
Mutagenicity and Carcinogenicity
2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Toxicity Testing in Animals
40
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
40


